Cardiac manifestations in Behcet's disease

Review ArticleAçık Erişim

Özet

Behcet's disease (BD) is a chronic inflammatory disorder, with vasculitis underlying the pathophysiology of its multisystemic effects. Venous pathology and thrombotic complications are hallmarks of BD. However, it has been increasingly recognised that cardiac involvement and arterial complications are also important aspects of the course of the disease. Cardiac lesions include pericarditis, endocarditis, intracardiac thrombosis, myocardial infarction, endomyocardial fibrosis, and myocardial aneurysm. Treatment of cardiovascular involvement in BD is largely empirical, and is aimed towards suppressing the vasculitis. The most challenging aspect seems to be the treatment of arterial aneurysms and thromboses due to the associated risk of bleeding. When the prognosis of cardiac involvement in BD is not good, recovery can be achieved through oral anticoagulation, immunosuppressive therapy, and colchicine use. In this review, we summarise the cardiovascular involvement, different manifestations, and treatment of BD.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/16994Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5582/irdr.2015.01007Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDemirelli, Selami
dc.contributor.authorDegirmenci, Husnu
dc.contributor.authorInci, Sinan
dc.contributor.authorArisoy, Arif
dc.date.accessioned2026-10-18T20:41:11.948314945Z
dc.date.available2026-10-18T20:41:11.948314945Z
dc.date.issued2015
dc.description.abstractBehcet's disease (BD) is a chronic inflammatory disorder, with vasculitis underlying the pathophysiology of its multisystemic effects. Venous pathology and thrombotic complications are hallmarks of BD. However, it has been increasingly recognised that cardiac involvement and arterial complications are also important aspects of the course of the disease. Cardiac lesions include pericarditis, endocarditis, intracardiac thrombosis, myocardial infarction, endomyocardial fibrosis, and myocardial aneurysm. Treatment of cardiovascular involvement in BD is largely empirical, and is aimed towards suppressing the vasculitis. The most challenging aspect seems to be the treatment of arterial aneurysms and thromboses due to the associated risk of bleeding. When the prognosis of cardiac involvement in BD is not good, recovery can be achieved through oral anticoagulation, immunosuppressive therapy, and colchicine use. In this review, we summarise the cardiovascular involvement, different manifestations, and treatment of BD.
dc.identifier.doi10.5582/irdr.2015.01007
dc.identifier.eissn2186-361X
dc.identifier.endpage75
dc.identifier.issn2186-3644
dc.identifier.issue2
dc.identifier.startpage70
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/16994
dc.identifier.volume4
dc.identifier.wosWOS:000218880200002
dc.language.isoen
dc.publisherINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
dc.relation.ispartofINTRACTABLE & RARE DISEASES RESEARCH
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBehcet's disease
dc.subjectcardiac manifestations
dc.subjecttreatment
dc.subjectMedicine, General & Internal
dc.subjectGeneral & Internal Medicine
dc.titleCardiac manifestations in Behcet's disease
dc.typeReview Article
dspace.entity.typePublication
rdl.citation.wos99
rdl.oa.statusgreen
rdl.source.indexWOS
rdl.wos.indexEmerging Sources Citation Index (ESCI)